(Q24242089)

English

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults

scientific article

In more languages

Statements

scholarly article

0 references

0 references

1 reference

Europe PubMed Central

High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults (English)

0 references

0 references

stem cell transplantation

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

2

0 references

6

0 references

Guido Schwarzer

4

0 references

author name string

Alexander Greb

1

0 references

Daniel Schiefer

3

0 references

Holger Schulz

5

0 references

publication date

23 January 2008

0 references

Cochrane Database of Systematic Reviews

0 references

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Randomized study to evaluate the use of high-dose therapy as part of primary treatment for "aggressive" lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Early autologous stem-cell transplantation versus conventional chemotherapy as front-line therapy in high-risk, aggressive non-Hodgkin's lymphoma: an Italian multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Autologous stem cell transplantation for anaplastic large-cell lymphomas: results of a prospective trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSG.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

A review of recruitment criteria, patient characteristics and results of CHOP chemotherapy in prospective randomized phase III clinical trials for aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. The GELA (Groupe d'Etude des Lymphomes Agressives).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI).

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Identifying relevant studies for systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Individual patient-versus literature-based meta-analysis of survival data: time to event and event rate at a particular time can make a difference, an example based on head and neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Bias in location and selection of studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Treatment of aggressive non-hodgkin's lymphomas: Lessons from the past 10 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Autologous bone marrow transplantation in poor-prognosis intermediate-grade and high-grade B-cell non-Hodgkin's lymphoma in first remission: a pilot study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

What is meant by intention to treat analysis? Survey of published randomised controlled trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Prognostic significance of the immunophenotype versus the International Prognostic Index in aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

A comparison of meta-analytic results using literature vs individual patient data. Paternal cell immunization for recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Autologous stem cell transplantation for malignancy: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Meta-analysis of the literature or of individual patient data: is there a difference?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Phase II study of rituximab in combination with chop chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

The Delphi List

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

21 January 2018

Issues of efficiency in combining proportions of deaths from several clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation for aggressive non-Hodgkin's lymphomas in first complete or partial remission: a retrospective analysis of the outcome of 52 patients according to the age-adjusted International Prognostic Index

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

A quantitative study of peripheral blood stem cell contamination in diffuse large-cell non-Hodgkin's lymphoma: one-half of patients significantly mobilize malignant cells

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pounding in the neck in supraventricular tachycardia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of MACOP-B with CHOP in patients with intermediate-grade non-Hodgkin's lymphoma. The Australian and New Zealand Lymphoma Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Bl

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

CHOP versus CHOP plus ESHAP and high-dose therapy with autologous peripheral blood progenitor cell transplantation for high-intermediate-risk and high-risk aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004024.PUB2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/14651858.CD004024.PUB2

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24242089&oldid=1951999448"